These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 30945317)
1. What kind of 'a girls' thing'? Frictions and continuities in the framing and taming of the HPV vaccine in Finland. Virtanen MJ Sociol Health Illn; 2019 May; 41(4):789-805. PubMed ID: 30945317 [TBL] [Abstract][Full Text] [Related]
2. Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents. La Vincente SF; Mielnik D; Jenkins K; Bingwor F; Volavola L; Marshall H; Druavesi P; Russell FM; Lokuge K; Mulholland EK BMC Public Health; 2015 Dec; 15():1257. PubMed ID: 26684658 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras. Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157 [TBL] [Abstract][Full Text] [Related]
4. Adolescent girls' preferences for HPV vaccines: a discrete choice experiment. Brown DS; Poulos C; Johnson FR; Chamiec-Case L; Messonnier ML Adv Health Econ Health Serv Res; 2014; 24():93-121. PubMed ID: 25244906 [TBL] [Abstract][Full Text] [Related]
5. Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK. Datta S; Pink J; Medley GF; Petrou S; Staniszewska S; Underwood M; Sonnenberg P; Keeling MJ BMC Infect Dis; 2019 Jun; 19(1):552. PubMed ID: 31234784 [TBL] [Abstract][Full Text] [Related]
6. Girls' preferences for HPV vaccination: a discrete choice experiment. de Bekker-Grob EW; Hofman R; Donkers B; van Ballegooijen M; Helmerhorst TJ; Raat H; Korfage IJ Vaccine; 2010 Sep; 28(41):6692-7. PubMed ID: 20708696 [TBL] [Abstract][Full Text] [Related]
7. Correlates of human papillomavirus vaccine coverage: a state-level analysis. Moss JL; Reiter PL; Brewer NT Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program. Prinja S; Bahuguna P; Faujdar DS; Jyani G; Srinivasan R; Ghoshal S; Suri V; Singh MP; Kumar R Cancer; 2017 Sep; 123(17):3253-3260. PubMed ID: 28472550 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia. Aljunid S; Maimaiti N; Nur AM; Noor MRM; Wan Puteh SE BMC Public Health; 2016 Jan; 16():71. PubMed ID: 26803814 [TBL] [Abstract][Full Text] [Related]
11. Hispanic mothers' and high school girls' perceptions of cervical cancer, human papilloma virus, and the human papilloma virus vaccine. Morales-Campos DY; Markham CM; Peskin MF; Fernandez ME J Adolesc Health; 2013 May; 52(5 Suppl):S69-75. PubMed ID: 23601613 [TBL] [Abstract][Full Text] [Related]
12. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers. Gerend MA; Shepherd MA; Lustria ML Sex Transm Dis; 2013 May; 40(5):401-5. PubMed ID: 23588130 [TBL] [Abstract][Full Text] [Related]
13. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA). Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822 [TBL] [Abstract][Full Text] [Related]
14. Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination. Palmroth J; Merikukka M; Paavonen J; Apter D; Eriksson T; Natunen K; Dubin G; Lehtinen M Int J Cancer; 2012 Dec; 131(12):2832-8. PubMed ID: 22492244 [TBL] [Abstract][Full Text] [Related]
15. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges. Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574 [TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan. Tang CH; Cheng WF; Jiang JH; You SL; Huang LW; Hsieh JY; Mukherjee P; Van Kriekinge G; Lee C Asian Pac J Cancer Prev; 2019 May; 20(5):1377-1387. PubMed ID: 31127896 [TBL] [Abstract][Full Text] [Related]
17. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium. Demarteau N; Van Kriekinge G; Simon P Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952 [TBL] [Abstract][Full Text] [Related]
18. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Burger EA; Campos NG; Sy S; Regan C; Kim JJ Vaccine; 2018 Aug; 36(32 Pt A):4823-4829. PubMed ID: 29807710 [TBL] [Abstract][Full Text] [Related]
19. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749 [TBL] [Abstract][Full Text] [Related]
20. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model. Gomez JA; Lepetic A; Demarteau N BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]